RT Book, Section A1 Agrawal, Rishi A1 Murphy, Nancy A2 Zaoutis, Lisa B. A2 Chiang, Vincent W. SR Print(0) ID 1146124514 T1 Introduction to the Child with Medical Complexity T2 Comprehensive Pediatric Hospital Medicine, 2e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9780071829281 LK accesspediatrics.mhmedical.com/content.aspx?aid=1146124514 RD 2024/04/25 AB The care of children with medical complexity (CMC) is an increasingly central component of pediatric hospital medicine. While there is no consensus definition for this population, a recent conceptual framework posits four key domains: high levels of family-identified needs, severe chronic conditions, significant functional limitations, and elevated health resource utilization.1 CMC include children with static or progressive neurologic, neuromuscular, and genetic or acquired conditions that require the assistance of medical technologies such as gastrostomy or tracheostomy, require care from multiple subspecialists and therapists, and have significant family-identified needs for care coordination across the continuum of care. For example, children with quadriplegic cerebral palsy, muscular dystrophies, congenital myopathies, high myelomeningoceles, and glycogen storage diseases such as Morquio syndrome have medical complexities. For some conditions with a wide variety of severity of manifestations, a subset of more severely affected patients would be considered medically complex. For instance, a child with sickle cell disease with multiple comorbidities (pulmonary hypertension, stroke, etc.) and/or medical fragility (e.g. frequent hospitalizations for crises) would also be considered medically complex. Health services researchers use a variety of methods to identify such children from diagnostic (ICD-9) codes, such as the Complex Chronic Conditions, 3M Clinical Risk Groups (CRG), and Neurological Impairment codes.2-4 The National Survey of Children with Special Health Care Needs has also been analyzed in a way to identify such children at a population level, suggesting a population prevalence of 0.4%.5